Works matching DE "DARATUMUMAB"

Results: 323
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Exposure‐Response and Population Pharmacokinetic Analyses of a Novel Subcutaneous Formulation of Daratumumab Administered to Multiple Myeloma Patients.

    Published in:
    Journal of Clinical Pharmacology, 2021, v. 61, n. 5, p. 614, doi. 10.1002/jcph.1771
    By:
    • Luo, Man (Melody);
    • Usmani, Saad Z.;
    • Mateos, Maria‐Victoria;
    • Nahi, Hareth;
    • Chari, Ajai;
    • San‐Miguel, Jesus;
    • Touzeau, Cyrille;
    • Suzuki, Kenshi;
    • Kaiser, Martin;
    • Carson, Robin;
    • Heuck, Christoph;
    • Qi, Ming;
    • Zhou, Honghui;
    • Sun, Yu‐Nien;
    • Parasrampuria, Dolly A.
    Publication type:
    Article
    17
    18

    Daratumumab, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide, and Dexamethasone in Transplant‐Ineligible Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Meta‐Analysis.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 3, p. 1, doi. 10.1002/hon.70061
    By:
    • Gordan, Lucio N.;
    • Medhekar, Rohan;
    • Fu, Alex Z.;
    • Shokoohi, Mostafa;
    • Oliva Ramirez, Abril;
    • Bonar, Nicolle;
    • Nguyen, Bao‐Ngoc;
    • Spence, Michaela;
    • McTavish, Rebecca;
    • Disher, Tim;
    • Gautam, Santosh;
    • Gupta‐Werner, Niodita;
    • Kaila, Shuchita;
    • Patel, Anjan J.
    Publication type:
    Article
    19

    Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab‐Refractory Multiple Myeloma Patients: A Multicenter Real‐World Study.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 2, p. 1, doi. 10.1002/hon.70042
    By:
    • Martino, Enrica Antonia;
    • Derudas, Daniele;
    • Rossi, Elena;
    • Stefanoni, Paola;
    • Mangiacavalli, Silvia;
    • Zamagni, Elena;
    • Offidani, Massimo;
    • Furlan, Anna;
    • Quinto, Angela Maria;
    • Della Pepa, Roberta;
    • Bertuglia, Giuseppe;
    • Barbieri, Emiliano;
    • Conticello, Concetta;
    • De Magistris, Claudio;
    • Bongarzoni, Velia;
    • Cafro, Anna Maria;
    • Mele, Anna;
    • Botta, Cirino;
    • Sgherza, Nicola;
    • Mele, Giuseppe
    Publication type:
    Article
    20

    A real‐life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis.

    Published in:
    Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3289
    By:
    • Bellofiore, Claudia;
    • Benvenuti, Pietro;
    • Mina, Roberto;
    • Basset, Marco;
    • Foli, Andrea;
    • Nanci, Martina;
    • Nuvolone, Mario;
    • Guida, Gianluigi;
    • Attanasio, Andrea;
    • Mussinelli, Roberta;
    • Mangiacavalli, Silvia;
    • Cartia, Claudio Salvatore;
    • Masoni, Valeria;
    • Palumbo, Michele;
    • Cani, Lorenzo;
    • Oliva, Stefania;
    • Consoli, Ugo;
    • Conticello, Concetta;
    • Di Raimondo, Francesco;
    • Arcaini, Luca
    Publication type:
    Article
    21
    22
    23

    Network meta‐analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 987, doi. 10.1002/hon.3041
    By:
    • Botta, Cirino;
    • Gigliotta, Emilia;
    • Paiva, Bruno;
    • Anselmo, Rita;
    • Santoro, Marco;
    • Otero, Paula Rodriguez;
    • Carlisi, Melania;
    • Conticello, Concetta;
    • Romano, Alessandra;
    • Solimando, Antonio Giovanni;
    • Cerchione, Claudio;
    • Vià, Matteo Da;
    • Bolli, Niccolò;
    • Correale, Pierpaolo;
    • Di Raimondo, Francesco;
    • Gentile, Massimo;
    • San Miguel, Jesus;
    • Siragusa, Sergio
    Publication type:
    Article
    24

    Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 4, p. 521, doi. 10.1002/hon.2906
    By:
    • Højholt, Karen Louise;
    • Gregersen, Henrik;
    • Szabo, Agoston Gyula;
    • Klausen, Tobias Wirenfeldt;
    • Levring, Mette Bøegh;
    • Preiss, Birgitte;
    • Helleberg, Carsten;
    • Breinholt, Marie Fredslund;
    • Hermansen, Emil;
    • Rahbek Gjerdrum, Lise Mette;
    • Bønløkke, Søren Thorgaard;
    • Nielsen, Katrine;
    • Kjeldsen, Eigil;
    • Iversen, Katrine Fladeland;
    • Teodorescu, Elena Manuela;
    • Kurt, Eva;
    • Strandholdt, Casper;
    • Andersen, Mette Klarskov;
    • Vangsted, Annette Juul
    Publication type:
    Article
    25
    26
    27

    Pomalidomide combinations are a safe and effective option after daratumumab failure.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 6569, doi. 10.1007/s00432-023-04637-x
    By:
    • Brioli, Annamaria;
    • Gengenbach, Laura;
    • Mancuso, Katia;
    • Binder, Mascha;
    • Ernst, Thomas;
    • Heidel, Florian H.;
    • Stauch, Thomas;
    • Zamagni, Elena;
    • Hilgendorf, Inken;
    • Hochhaus, Andreas;
    • Engelhardt, Monika;
    • von Lilienfeld-Toal, Marie
    Publication type:
    Article
    28

    Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 2, p. 619, doi. 10.1007/s00432-020-03365-w
    By:
    • Usmani, Saad Z.;
    • Mateos, Maria-Victoria;
    • Hungria, Vania;
    • Iida, Shinsuke;
    • Bahlis, Nizar J.;
    • Nahi, Hareth;
    • Magen, Hila;
    • Cavo, Michele;
    • Hulin, Cyrille;
    • White, Darrell;
    • De Stefano, Valerio;
    • Fastenau, John;
    • Slavcev, Mary;
    • Heuck, Christoph;
    • Qin, Xiang;
    • Pei, Huiling;
    • Masterson, Tara;
    • Lantz, Kristen;
    • Gries, Katharine S.
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region (REPAIR Study).

    Published in:
    Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1547138
    By:
    • Alhejazi, Ayman;
    • Alhuraiji, Ahmad;
    • Nourallah, Abdulnaser;
    • Alshehri, Abdulrahman;
    • Usman, Binyam;
    • ElGohary, Ghada;
    • Malhan, Hafiz;
    • Motabi, Ibraheem;
    • Farsi, Khalil Al;
    • Alshuaibi, Mohammed;
    • Diab, Mohanad;
    • Siddiqui, Mustaqeem;
    • Taha, Ruba Yasin;
    • Abouzeid, Tarek;
    • Ahmed, Wesam;
    • Ali, Ahmed Ramadan;
    • Ghonema, Rasha;
    • Elkhazin, Sana Faysal;
    • Moussa, Yousra;
    • Alrajhi, Abdullah M.
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50